Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Lisa B. Bland"'
Autor:
Jonathan Q. Purnell, Lisa B. Bland, Mark Garzotto, Dianne Lemmon, Emily M. Wersinger, Christopher W. Ryan, John D. Brunzell, Tomasz M. Beer
Publikováno v:
Journal of Lipid Research, Vol 47, Iss 2, Pp 349-355 (2006)
Androgen deprivation therapy (ADT) for prostate cancer is now used in earlier disease stages and as adjuvant treatment. Recognizing and reducing the toxicity of this therapy, including worsened lipid levels and cardiovascular disease (CVD) risks, has
Externí odkaz:
https://doaj.org/article/f5046fa8e5514dd29ccec6a02e1bb382
Autor:
Lisa B. Bland, Tomasz M. Beer, Dianne Lemmon, Emily M. Wersinger, John D. Brunzell, Christopher W. Ryan, Jonathan Q. Purnell, Mark Garzotto
Publikováno v:
Journal of Lipid Research, Vol 47, Iss 2, Pp 349-355 (2006)
Androgen deprivation therapy (ADT) for prostate cancer is now used in earlier disease stages and as adjuvant treatment. Recognizing and reducing the toxicity of this therapy, including worsened lipid levels and cardiovascular disease (CVD) risks, has
Publikováno v:
Journal of Urology. 172:2213-2217
Previously reported association of anemia with shorter survival in newly diagnosed metastatic prostate cancer may simply reflect extent of disease. The impact of anemia on response to androgen deprivation is not known. We examined the prognostic valu
Publikováno v:
Clinical Prostate Cancer. 2:167-172
We sought to determine whether age was significantly associated with efficacy and toxicity of weekly docetaxel in patients with metastatic androgen-independent prostate cancer (AIPC). Individual patient data were pooled from 2 phase II clinical trial
Parenteral estrogens for prostate cancer: can a new route of administration overcome old toxicities?
Publikováno v:
Clinical genitourinary cancer. 5(3)
Androgen deprivation therapy (ADT) is the mainstay of management of advanced-stage prostate cancer and recently has been shown to improve survival when administered in earlier stages of the disease. The oncologic benefits of ADT might be partially of
Autor:
Catherine M. Tangen, Bryan Goldman, Thomas G. DeLoughery, Maha Hussain, Tomasz M. Beer, Lisa B. Bland, E. David Crawford
Publikováno v:
Cancer. 107(3)
The objective of this study was to characterize changes in hemoglobin (HGB) levels after the initiation of androgen-deprivation therapy (ADT) in patients with previously untreated, metastatic prostate cancer who were enrolled in a large clinical tria
Autor:
Michelle B. Neiss, Mark Garzotto, Jeri S. Janowsky, Tomasz M. Beer, Joseph R. Bussiere, Christopher W. Ryan, Lisa B. Bland, Emily M. Wersinger
Publikováno v:
The Journal of urology. 175(1)
Little is known about the effect of androgen deprivation therapy on the brain despite the fact that sex steroid receptors are abundant in cortical brain regions that mediate memory and other cognitive functions. We characterized the impact of androge
Autor:
Lisa B. Bland, Christopher W. Ryan, Mark Garzotto, Emily M. Wersinger, Kathryn G. Schuff, Tomasz M. Beer, Thomas G. DeLoughery, Dianne Lemmon
Publikováno v:
Cancer. 103(4)
BACKGROUND Oral estrogen therapy has activity in patients with hormone-naive and androgen-independent prostate carcinoma (AIPC), but its utility is limited by the associated risk of thromboembolic toxicity. Parenteral administration may be safer as i
Publikováno v:
Clinical prostate cancer. 2(3)
We sought to determine whether age was significantly associated with efficacy and toxicity of weekly docetaxel in patients with metastatic androgen-independent prostate cancer (AIPC). Individual patient data were pooled from 2 phase II clinical trial
Autor:
Catherine M. Tangen, Tomasz M. Beer, Bryan Goldman, Thomas G. DeLoughery, Maha Hussain, Lisa B. Bland, E. David Crawford
Publikováno v:
Journal of Urology. 175:385-386